Epigenetic regulation of NKG2D ligands is involved in exacerbated atherosclerosis development in Sirt6 heterozygous mice

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhang, Zhu Qin ^a   Ren, Si Chong ^a   Tan, Ying ^a   Li, Zuo Zhi ^a   Tang, Xiaoqiang ^a   Wang, Ting Ting ^a   Hao, De Long ^a   Zhao, Xiang ^a   Chen, Hou Zao ^a   Liu, De Pei ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; KLRK1 PROTEIN, MOUSE; LIGAND; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; SIRT6 PROTEIN, MOUSE; SIRTUIN;

ANIMAL; ATHEROSCLEROTIC PLAQUE; CAROTID ENDARTERECTOMY; FEMALE; FIBROBLAST; GENETIC EPIGENESIS; GENETICS; HETEROZYGOTE; HUMAN; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; PROMOTER REGION; SIGNAL TRANSDUCTION;

ANIMALS; APOLIPOPROTEINS E; ENDARTERECTOMY, CAROTID; EPIGENESIS, GENETIC; FEMALE; FIBROBLASTS; HETEROZYGOTE; HUMANS; LIGANDS; MALE; MICE; MICE, KNOCKOUT; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PLAQUE, ATHEROSCLEROTIC; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; SIRTUINS;

EID: 84964068185     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23912     Document Type: Article

References (34)

1. Hansson G. K., Libby P., Schonbeck U., & Yan Z. Q. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91, 281-291 (2002
2. Selathurai A., et al. Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms. Cardiovasc Res 102, 128-137 (2014
3. Braun N. A., Covarrubias R., & Major A. S. Natural killer T cells and atherosclerosis: form and function meet pathogenesis. J Innate Immun 2, 316-324 (2010
4. Tedgui A., & Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86, 515-581 (2006
5. Kleemann R., Zadelaar S., & Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 79, 360-376 (2008
6. Galkina E., & Ley K. Immune and inflammatory mechanisms of atherosclerosis (∗). Annu Rev Immunol 27, 165-197 (2009
7. Sauve A. A., Wolberger C., Schramm V. L., & Boeke J. D. The biochemistry of sirtuins. Annu Rev Biochem 75, 435-465 (2006
8. Mostoslavsky R., et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124, 315-329 (2006
9. Kanfi Y., et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature 483, 218-221 (2012
10. Sebastian C., et al. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151, 1185-1199 (2012
11. Min L., et al. Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat Cell Biol 14, 1203-1211 (2012
12. Marquardt J. U., et al. Sirtuin-6-dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patients. Hepatology 58, 1054-1064 (2013
13. Sundaresan N. R., et al. The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun. Nat Med 18, 1643-1650 (2012
14. Bots M. L., Hoes A. W., Koudstaal P. J., Hofman A., & Grobbee D. E. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 96, 1432-1437 (1997
15. Finn A. V., Nakano M., Narula J., Kolodgie F. D., & Virmani R. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 30, 1282-1292 (2010
16. Koenig W., & Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol 27, 15-26 (2007
17. Xia M., et al. Immune activation resulting from NKG2D/ligand interaction promotes atherosclerosis. Circulation 124, 2933-2943 (2011
18. Zhang H., Hardamon C., Sagoe B., Ngolab J., & Bui J. D. Studies of the H60a locus in C57BL/6 and 129/Sv mouse strains identify the H60a 3?UTR as a regulator of H60a expression. Mol Immunol 48, 539-545 (2011
19. Major A. S., & Harrison D. G. What fans the fire: insights into mechanisms of inflammation in atherosclerosis and diabetes mellitus. Circulation 124, 2809-2811 (2011
20. Jamieson A. M., et al. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17, 19-29 (2002
21. Michishita E., et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452, 492-496 (2008
22. Michishita E., et al. Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle 8, 2664-2666 (2009
23. Dominy J. E. Jr., et al. The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis. Mol Cell 48, 900-913 (2012
24. Dong C., et al. Association of the sirtuin and mitochondrial uncoupling protein genes with carotid plaque. PLoS One 6, e27157 (2011
25. Balestrieri M. L., et al. Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment. Diabetes 64, 1395-1406 (2015
26. Guerra N., et al. A selective role of NKG2D in inflammatory and autoimmune diseases. Clin Immunol 149, 432-439 (2013
27. Ikeshita S., Miyatake Y., Otsuka N., & Kasahara M. MICA/B expression in macrophage foam cells infiltrating atherosclerotic plaques. Exp Mol Pathol 97, 171-175 (2014
28. Rodriguez J. M., et al. Altered expression of Raet1e, a major histocompatibility complex class 1-like molecule, underlies the atherosclerosis modifier locus Ath11 10b. Circ Res 113, 1054-1064 (2013
29. Zhang R., et al. SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages. J Biol Chem 285, 7097-7110 (2010
30. Van Gool F., et al. Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner. Nat Med 15, 206-210 (2009
31. Tennen R. I., Bua D. J., Wright W. E., & Chua K. F. SIRT6 is required for maintenance of telomere position effect in human cells. Nat Commun 2, 433 (2011
32. Luo J., et al. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nature protocols 2, 1236-1247 (2007
33. Wang Y., et al. Noninvasive assessment of atherosclerosis in apolipoprotein-e knockout mice by ultrasound biomicroscopy. Ultrasound in medicine, & biology 37, 892-899 (2011
34. She Z. G., et al. Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice. Circ Res 104, 1160-1168 (2009